TITLE

CLINICAL EXPERIENCES WITH THE ANTICOAGULANT COUMADIN (WARFARIN) SODIUM

AUTHOR(S)
Kerrin, Hugh F.; J. Guidot; Wilfelm, S. K.
PUB. DATE
June 1957
SOURCE
Angiology;Jun1957, Vol. 8 Issue 3, p302
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines the difference in the efficacy of warfarin sodium and phenylindandione. Tendency of phenylindandione to accumulate in the body; Average dose of warfarin sodium; Indication of better control with warfarin sodium.
ACCESSION #
16351863

 

Related Articles

  • Quantification of Apixaban's Therapeutic Utility in Prevention of Venous Thromboembolism: Selection of Phase III Trial Dose. Leil, T. A.; Feng, Y.; Zhang, L.; Paccaly, A.; Mohan, P.; Pfister, M. // Clinical Pharmacology & Therapeutics;Sep2010, Vol. 88 Issue 3, p375 

    A model-based approach was used to integrate data from a phase II study in order to provide a quantitative rationale for selecting the apixaban dosage regimen for a phase III trial. The exposure–response models demonstrated that an increase in daily steady-state area under the plasma...

  • EFFECT OF AGE ON WARFARIN DOSE REQUIREMENT IN PAKISTANI POPULATION. Qayyum, Aisha; Shafiq, Hamid; Najmi, Muzammil Hasan; Naveed, Abdul Khaliq // Pakistan Heart Journal;2014, Vol. 47 Issue 2, p61 

    Objective: The study was conducted to determine the effect of age on warfarin dose requirement in Pakistani population. Methodology: This cross-sectional study was carried out at Armed Forces Institute of Cardiology (AFIC) Rawalpindi, Military Hospital Rawalpindi and National Institute of...

  • The Critical Path of Warfarin Dosing: Finding an Optimal Dosing Strategy Using Pharmacogenetics. Lesko, L. J. // Clinical Pharmacology & Therapeutics;Sep2008, Vol. 84 Issue 3, p301 

    The article reports on incidents of warfarin's side effects on patients 65 years old and above as supported by the U.S. Food and Drug Administration's Adverse (FDA)Event Reporting System. It also presents an optimal warfarin dosing that follows a scientific and clinically rational approach as...

  • DOSING CONVERSION FOR ANTICOAGULANTS: DABIGATRAN/HEPARIN/WARFARIN.  // Monthly Prescribing Reference;Sep2011, Vol. 27 Issue 9, p52 

    The article offers information related to the conversion of the dosages of several anticoagulants including Dabigatran Etexilate, Heparin, and Warfarin.

  • A new target for aspirin. O'Neill, Edward A. // Nature;11/5/1998, Vol. 396 Issue 6706, p15 

    Discusses concerns pertaining to the differences in the clinical activities of low and high dosages of aspirin. Indications that aspirin inhibits the cycloxygenases; How the anti-flammatory efficacy of aspirin can be limited; Inability of aspirin to prevent rheumatoid arthritis, which is the...

  • Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma. Phillips K; Oborne J; Harrison T W; Tattersfield A E // Thorax;Jan2004, Vol. 59 Issue 1, p21 

    BACKGROUND: Inhaled corticosteroids are widely used to treat asthma. There is a need to be able to compare different inhaled corticosteroids and different doses of an inhaled corticosteroid to determine potency and dose equivalence, but measuring efficacy in a dose related manner is difficult...

  • Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Phillips K; Oborne J; Lewis S; Harrison T W; Tattersfield A E // Thorax;Jan2004, Vol. 59 Issue 1, p26 

    BACKGROUND: It is important to be able to compare the efficacy and systemic effects of inhaled corticosteroids but their slow onset of action makes it difficult to measure the maximum response to a given dose. Submaximal responses could be compared if the time course of action of the inhaled...

  • WHY IT'S TIME TO SAY GOODBYE TO STAVUDINE ... EVERYWHERE. Andrieux-Meyer, Isabelle; Clayden, Polly; Collins, Simon; Geffen, Nathan; Goemaere, Eric; Harrington, Mark; Lynch, Sharonann; Schoen-Angerer, Tido von; Swan, Tracy // Southern African Journal of HIV Medicine;Mar2012, Vol. 13 Issue 1, p17 

    The article offers the author's perspective on a proposed study on the use of low-dose stavudine in paediatrics. The authors offer their serious concerns about the proposed trial, highlighting the risk associated with the drug. They add that stavudine is more toxic than tenofovir, thus it is an...

  • The benefits of high doses of vitamin E. Scott, Linda // GP: General Practitioner;2/25/2002, p71 

    Discusses the advantages of taking high dosage of vitamin E. Benefits of the antioxidant to the system; Inverse association between estimated dietary intake of the vitamins and risk of CHD; Prevention of diseases associated with oxidative stress.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics